{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T17:38:08Z","timestamp":1781285888162,"version":"3.54.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.pnpbp.2009.10.022","type":"journal-article","created":{"date-parts":[[2009,11,8]],"date-time":"2009-11-08T04:07:05Z","timestamp":1257653225000},"page":"177-182","source":"Crossref","is-referenced-by-count":26,"title":["Interleukin 6\u2013174 G\/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease"],"prefix":"10.1016","volume":"34","author":[{"given":"Cristiano","family":"Capurso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Solfrizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Colacicco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"D'Introno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenza","family":"Frisardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno P.","family":"Imbimbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Lorusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Vendemiale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Denitto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Santamato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Seripa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Pilotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Capurso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Panza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2009.10.022_bib1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1086\/316944","article-title":"Extent and distribution of linkage disequilibrium in three genomic regions","volume":"68","author":"Abecasis","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0278-5846(91)90023-T","article-title":"Cytokines in Alzheimer's disease","volume":"15","author":"Altstiel","year":"1991","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib3","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.neurobiolaging.2003.10.009","article-title":"Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease","volume":"25","author":"Arosio","year":"2004","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0304-3940(00)00917-4","article-title":"Association between an interleukin-6 promoter and 30 flanking region haplotype and reduced Alzheimer's disease risk in a German population","volume":"283","author":"Bagli","year":"2000","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00406-003-0405-x","article-title":"Polymorphisms of the gene encoding the inflammatory cytokine interleukin-6 determine the magnitude of the increase in soluble interleukin-6 receptor levels in Alzheimer's disease. Results of a pilot study","volume":"253","author":"Bagli","year":"2003","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng1934","article-title":"Systematic meta-analyses of Alzheimer disease genetic association studies: the Alzgene database","volume":"39","author":"Bertram","year":"2007","journal-title":"Nature Genetics"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0304-3940(00)01185-X","article-title":"Genetic polymorphism in the Cathepsin D and interleukin-6 genes and the risk of Alzheimer's disease","volume":"288","author":"Bohjak","year":"2000","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib8","doi-asserted-by":"crossref","first-page":"6855","DOI":"10.1093\/nar\/17.17.6855","article-title":"Rapid detection and sequencing of alleles in the 3' flanking region of the interleukin-6 gene","volume":"17","author":"Bowcock","year":"1989","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/sj.mp.4000225","article-title":"Transgenic models to assess the pathogenic actions of cytokines in the central nervous system","volume":"2","author":"Campbell","year":"1997","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib10","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.exger.2004.03.037","article-title":"Interleukin 6\u2013174 G\/C promoter gene polymorphism in centenarians: no evidence of association with human longevity or interaction with apolipoprotein E alleles","volume":"39","author":"Capurso","year":"2004","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib11","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.exger.2004.07.006","article-title":"Interleukin 6\u2013174 G\/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe","volume":"39","author":"Capurso","year":"2004","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib12","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1469-1809.2007.00368.x","article-title":"Interleukin 6 variable number of tandem repeats (VNTR) gene polymorphism in centenarians","volume":"71","author":"Capurso","year":"2007","journal-title":"Ann Hum Genet"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib13","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00415-005-0658-6","article-title":"Interaction between interleukin-6 and intercellular adhesion molecule-1 genes and Alzheimer's disease risk","volume":"252","author":"Combarros","year":"2005","journal-title":"J Neurol"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib14","article-title":"Replication by the Epistasis Project of the interaction between the genes for IL-6 and IL-10 in the risk of Alzheimer's disease","volume":"22","author":"Combarros","year":"2009","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib15","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000076352","article-title":"An interleukin-6 promoter variant is not associated with an increased risk for Alzheimer's disease","volume":"17","author":"Depboylu","year":"2004","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib16","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1750-3639.1998.tb00166.x","article-title":"Microglial activation in Alzheimer disease: association with APOE genotype","volume":"8","author":"Egensperger","year":"1998","journal-title":"Brain Pathol"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib17","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1001\/archneur.61.5.668","article-title":"Inflammatory proteins in plasma and the risk of dementia: the Rotterdam study","volume":"61","author":"Engelhart","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib18","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1046\/j.1532-5415.2003.51177.x","article-title":"Interleukin-6\u2013174 G\/C promoter gene polymorphism C allele reduces Alzheimer's disease risk","volume":"51","author":"Faltraco","year":"2003","journal-title":"J Am Geriatrics Soc"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib19","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1172\/JCI2629","article-title":"The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis","volume":"102","author":"Fishman","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u00abMini-Mental State\u00bb: a practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib21","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1007\/s00415-009-5080-z","article-title":"Gene\u2013gene interaction between CARD8 and interleukin-6 reduces Alzheimer's disease risk","volume":"256","author":"Fontalba","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/gepi.1370090302","article-title":"Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world","volume":"9","author":"Gerdes","year":"1992","journal-title":"Genet Epidemiol"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0166-4328(95)00213-8","article-title":"The participation of interleukin-6, a stress-inducible cytokine, in the pathogenesis of Alzheimer's disease","volume":"78","author":"H\u00fcll","year":"1996","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib25","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1192\/bjp.140.6.566","article-title":"A new clinical scale for the staging of dementia","volume":"140","author":"Hughes","year":"1982","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib26","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1212\/01.WNL.0000138570.96291.A8","article-title":"Gene\u2013gene interaction between interleukin-6 and interleukin-10 reduces AD risk","volume":"63","author":"Infante","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib27","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2190\/UURL-2RYU-WRYD-EY3K","article-title":"A measure of primary sociobiological functions","volume":"6","author":"Katz","year":"1976","journal-title":"Int. J. Health Serv"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/01677060600569721","article-title":"Interleukin-6 promoter polymorphism and late-onset Alzheimer's disease in the Finnish population","volume":"19","author":"Koivisto","year":"2005","journal-title":"J Neurogenet"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/geront\/9.3_Part_1.179","article-title":"Assessment of older people: self-maintaining and instrumental activities of daily living","volume":"9","author":"Lawton","year":"1969","journal-title":"Gerontologist"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/archneurol.2007.3","article-title":"Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease","volume":"65","author":"Li","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib31","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0197-4580(03)00013-7","article-title":"Interleukin-6 gene alleles affect the risk of Alzheimer's disease and levels of the cytokine in blood and brain","volume":"24","author":"Licastro","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib32","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.neurobiolaging.2006.07.007","article-title":"Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation","volume":"28","author":"Licastro","year":"2007","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib33","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.STR.14.3.399","article-title":"Diagnostic evaluation of degenerative and vascular dementia","volume":"14","author":"Loeb","year":"1983","journal-title":"Stroke"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib34","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/jnnp.2005.075358","article-title":"Interaction between dopamine beta-hydroxylase and interleukin genes increases Alzheimer's disease risk","volume":"77","author":"Mateo","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib35","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S8756-3282(97)00081-1","article-title":"Polymorphisms of the interleukin-6 gene are associated with bone mineral density","volume":"21","author":"Murray","year":"1997","journal-title":"Bone"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib38","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neulet.2004.06.076","article-title":"Influence of polymorphisms in the genes for cytokines and glutathione S-transferase omega on sporadic Alzheimer's disease","volume":"368","author":"Nishimura","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib39","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/1531-8249(199905)45:5<666::AID-ANA18>3.0.CO;2-3","article-title":"A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease","volume":"45","author":"Papassotiropoulos","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0304-3940(99)00860-5","article-title":"Decreased frequency of apolipoprotein E epsilon4 allele from Northern to Southern Europe in Alzheimer's disease patients and centenarians","volume":"277","author":"Panza","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib41","first-page":"312","article-title":"Polymorphism 174 G\/C of interleukin 6 gene in Alzheimer's disease\u2014preliminary report","volume":"42","author":"Paradowski","year":"2008","journal-title":"Neurol Neurochir Pol"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib42","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/00001756-200209160-00015","article-title":"The -174 polymorphism of the interleukin-6 gene is associated with Alzheimer's disease in an Italian population","volume":"13","author":"Pola","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib43","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.exger.2005.10.005","article-title":"Interleukin-1beta and interleukin-6 gene polymorphisms as risk factors for AD: a prospective study","volume":"41","author":"Ravaglia","year":"2006","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib44","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/ajmg.10417","article-title":"Effect of IL-6 polymorphism on risk of Alzheimer's disease: genotype\u2013phenotype association study in Japanese cases","volume":"114","author":"Shibata","year":"2002","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib45","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1136\/jnnp.72.6.732","article-title":"Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's disease","volume":"72","author":"Solfrizzi","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib46","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.neulet.2006.03.050","article-title":"Polymorphisms in the interleukin 6 and transforming growth factor beta1 gene and risk of dementia: the Rotterdam study","volume":"402","author":"van Oijen","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib47","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1212\/WNL.59.3.371","article-title":"Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging","volume":"59","author":"Weaver","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.pnpbp.2009.10.022_bib48","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neulet.2004.03.008","article-title":"Interleukin-6 promoter polymorphism: risk and pathology of Alzheimer's disease","volume":"362","author":"Zhang","year":"2004","journal-title":"Neurosci Lett"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584609003856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584609003856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T08:53:24Z","timestamp":1544864004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584609003856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0278584609003856"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2009.10.022","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}